“…[151][152][153] In fact, a next-generation sequencing from RNA-seq to scRNA-seq, in particular combined with GWAS and/or DNA methylation analysis, [154][155][156] will identify novel susceptibility loci, reveal molecular characteristics and comprehensive cellular and molecular mechanisms. Different from whole-exome sequencing, [157,158] this new targeted and next-generation sequencing at the SC level, [159][160][161] that is scRNA-seq, [162][163][164] will definitely help to screen, diagnose, and treatment of CHD, [165] COVID, [166] and others.…”